Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 7/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24490500 | 0.90 | PDK2 (0.40) | PDK2KMT2ATDP1ALDH1A1NPC1 | |
| SCHEMBL24490439 | 0.89 | PDK2 (0.37) | PDK2MEN1KMT2AL3MBTL1TDP1 | |
| SCHEMBL24490442 | 0.87 | PDK2 (0.36) | PDK2MEN1KMT2AL3MBTL1TDP1 | |
| SCHEMBL24490441 | 0.86 | PDK2 (0.35) | PDK2MEN1KMT2AL3MBTL1TDP1 | |
| SCHEMBL24490484 | 0.81 | PDK2 (0.37) | PDK2 | |
| SCHEMBL28228760 | 0.80 | PDK2 (0.46) | PDK2KMT2AALDH1A1 | |
| SCHEMBL24497051 | 0.80 | PDK2 (0.38) | PDK2KMT2AL3MBTL1MAPTALDH1A1 | |
| SCHEMBL24490440 | 0.79 | PDK2 (0.39) | PDK2 | |
| SCHEMBL28531270 | 0.79 | PDK2 (0.41) | PDK2TDP1NPC1 | |
| SCHEMBL24490483 | 0.78 | PDK2 (0.38) | PDK2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20230242692-A1 | COMPOSITION AND CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230242692-A1 | COMPOSITION AND CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
| WO-2023127402-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING PATTERNED CURED FILM | 東京応化工業株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023127401-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING PATTERNED CURED FILM | 東京応化工業株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023120077-A1 | COMPOSITION, AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023120076-A1 | PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023074266-A1 | PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023074265-A1 | PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023074264-A1 | PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023058418-A1 | COMPOSITION, AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-04-13 | — | — | WO | disclosed |
| WO-2023047856-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-03-30 | — | — | WO | disclosed |
| WO-2023047855-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-03-30 | — | — | WO | disclosed |
| US-20230002520-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-01-05 | — | — | US | disclosed |
| WO-2022181562-A1 | PHOTOCURABLE LIQUID COMPOSITION, CURED OBJECT, AND METHOD FOR PRODUCING CURED OBJECT | 東京応化工業株式会社 | 2022-09-01 | — | — | WO | disclosed |
| US-20220177673-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-06-09 | — | — | US | disclosed |
| US-20220177641-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-06-09 | — | — | US | disclosed |
| US-20220177625-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177625-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND COMPOUND | CROCC, RCSD1, CRYZ | PDK2 4077/4885MEN1 2402/4885KMT2A 1167/4885 |
| US-20220177641-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND COMPOUND | CROCC, RCSD1, WDR5 | PDK2 4363/4885MEN1 1569/4885KMT2A 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.